嘉和美康(688246.SH)業績快報:2021年度淨利潤升125.75%至4800.57萬元
格隆匯2月28日丨嘉和美康(688246.SH)發佈2021年度業績快報,實現營業收入6.47億元,同比增長21.61%;歸屬於母公司所有者的淨利潤4800.57萬元,同比增長125.75%;歸屬於母公司所有者的扣除非經常性損益的淨利潤3805.3萬元,同比增長81.39%;基本每股收益0.46元。
影響經營業績的主要因素:(1)在國家關於電子病歷評級、互聯互通評測、推動公立醫院高質量發展等關注醫院信息化建設的政策影響下,2021年公司繼續加大市場拓展力度,受益於產品佈局符合當前行業發展趨勢、新產品的成熟度不斷提升等多重因素,在2021年全年均有新冠疫情影響的背景下,公司主營業務收入仍然保持了較好的增長趨勢。公司自產產品銷售和服務收入同比增長32.58%,佔比擴大7.45個百分點。
(2)2021年,新冠疫情在全國多地發生,一方面影響了醫院客户的正常業務開展,另一方面在部分時段限制了人員流動,導致公司在部分省市的業務開展受到了一定程度的不利影響。特別是第四季度疫情發生地涉及公司客户及項目集中的多個省份,致使部分項目驗收、項目收款工作受阻延後。
(3)2021年,公司對業務領域進行梳理,對業務佔比很小的醫療器械生產業務進行收縮關停,2021年相關收入減少1750.14萬元。
(4)2021年公司繼續加大研發投入,重點關注電子病歷智能化、專科化方向及數據利用方向,研發費用較上年增加34.85%,無資本化研發投入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.